Skip to main content
OpenTrials
Completed

NCT Number: NCT05640349

Evaluation of Bacteremia Epidemiology During the COVID Period in One French University Hospital

The main objective of this retrospective cohort is to evaluate the impact of the first epidemic wave during lockdown on bacteremia epidemiology in one French University Hospital.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

o Inclusion criteria : Patients with positive blood culture recorded at the microbiology laboratory of University Hospital of Nice Aged 18 years

o Exclusion criteria : Patients with negative blood culture recorded at the microbiology laboratory of University Hospital of Nice

Treatment and study plan

Positive blood culture

Biological

Positive blood culture recorded at the microbiology laboratory of University Hospital of Nic

Primary outcomes

  1. Epidemiology of bacteriemia,catheter-related infection and contamination

    Time frame: Day 0

    Describe and compare the incidence and epidemiology of hospital-diagnosed bacteriemia, catheter-related infection and contamination

Secondary outcomes

  1. Characterization of community bacteremia

    Time frame: Day 0

  2. Determined therapeutic actions

    Time frame: Day 0

    Anticipate the diagnostic and therapeutic actions to be taken for future epidemics

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Nice

Other

Registry information

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Dec 7, 2022
Registry last updated
Dec 7, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.